We are live on
!
Find out more
OCM
Opti Capital Management Portfolio holdings
AUM
$1.64B
1-Year Est. Return
0%
This Fund
S&P 500
This Quarter
Est. Return
-0.08%
1 Year Est. Return
0%
3 Year Est. Return
-0.01%
5 Year Est. Return
+0.33%
10 Year Est. Return
–
AUM
$210M
AUM Growth
–
Cap. Flow
+$985K
Cap. Flow
% of AUM
0.47%
Top 10 Holdings %
Top 10 Hldgs %
71.69%
Holding
25
New
3
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
|
+$564K |
| 2 |
Weibo
WB
|
+$381K |
| 3 |
Novavax
NVAX
|
+$38.8K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 99.76% |
| 2 | Communication Services | 0.18% |
| 3 | Healthcare | 0.07% |
Similar funds
MRG
MB
EPW
TWM
MA
HCMG
LFS
TIM
Opti Capital Management's Q4 2018 Portfolio in Review
Q4 2018 is the first quarter with a 13F filing on record for Opti Capital Management, which disclosed 25 positions worth $210M. Its ten largest holdings account for 72% of the portfolio.
Its largest position is Synergy Pharmaceuticals, Inc Common Stock: 860,221 shares worth $98K.
By sector, the portfolio is most concentrated in Miscellaneous at 100% of assets, followed by Communication Services and Healthcare.
- Opti Capital Management's largest Q4 2018 buy was Synergy Pharmaceuticals, Inc Common Stock: 860,221 shares worth $98K.
- Opti Capital Management's ten largest holdings make up 72% of its $210M portfolio in Q4 2018.
- Opti Capital Management disclosed 25 positions in Q4 2018, its first 13F filing on record.
Based on Opti Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.